<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/static/PubMed.dtd">
<ArticleSet><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>16</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2011</Year><Month>11</Month><Day>14</Day></PubDate></Journal><ArticleTitle>The protective role of endogenous nitric oxide donor (l -arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model</ArticleTitle><FirstPage>7587</FirstPage><LastPage>7587</LastPage><Language>EN</Language><AuthorList><Author><FirstName>Fatemeh</FirstName><LastName>Eshraghi-Jazi</LastName></Author><Author><FirstName>Mehdi</FirstName><LastName>Nematbakhsh</LastName><Affiliation>Professor, Kidney Basic Sciences Research Center and Department of Physiology, School of Medicine and Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. nematbakhsh@mui.ac.ir</Affiliation></Author><Author><FirstName>Hamid</FirstName><LastName>Nasri</LastName></Author><Author><FirstName>Ardeshir</FirstName><LastName>Talebi</LastName></Author><Author><FirstName>Maryam</FirstName><LastName>Haghighi</LastName></Author><Author><FirstName>Zahra</FirstName><LastName>Pezeshki</LastName></Author><Author><FirstName>Tahereh</FirstName><LastName>Safari</LastName></Author><Author><FirstName>Farzaneh</FirstName><LastName>Ashrafi</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2011</Year><Month>08</Month><Day>15</Day></PubDate><PubDate PubStatus="accepted"><Year>2011</Year><Month>11</Month><Day>03</Day></PubDate><PubDate PubStatus="revised"><Year>2011</Year><Month>10</Month><Day>26</Day></PubDate></History><Abstract>BACKGROUND: Cisplatin (CP) as a potential drug for solid tumors produces nephrotoxicity and disturbs endothelial function. CP induced nephrotoxicity may be gender related. Nitric oxide plays a pivotal role in endothelial function and L-arginine as endogenous NO donor promotes endothelial function. The role of L-arginine in CP induced nephrotoxicity model and its gender related was investigated in this study. METHODS: Thirty three Wistar rats were randomly assigned to four groups. The groups 1 (male, n = 6) and 2 (female, n = 11) received a single dose of L-arginine (300 mg/kg, ip), and the day after, they received a single dose of CP (7 mg/kg). The group 3 (male, n = 9) and 4 (female, n = 7) were assigned to the same regimen except for saline instead of L-arginine. All animals were sacrificed one week after CP administration. The levels of blood urea nitrogen (BUN), creatinine and nitrite were measured. The kidneys were also removed for pathological investigations. RESULTS: Five animals died. All CP treated animals lost weight. The normalized weigh loss was significantly different between male and female in CP+L-arginine treated animals (p &amp;lt; 0.05). BUN and creatinine were increased significantly in male treated with CP and in female treated with CP+L-arginine (p &amp;lt; 0.05). L-arginine reduced BUN in male (not in female) when compared with control groups (p &amp;lt; 0.05). The level of nitrite was increased significantly in L-arginine treated animals. Kidney tissue damage score and normalized kidney weight were greater in females treated with CP+L-arginine than female received CP alone (p &amp;lt; 0.05). CONCLUSIONS: L-arginine may protect against CP induced nephrotoxicity in male, but it promotes the induced damage in female. The exact mechanism need to be defined. KEYWORDS: Gender, L-arginine, Cisplatin, Nephrotoxicity, Rat</Abstract></Article></ArticleSet>
